María Carmona-Iragui Selected Research

Amyloid (Amyloid Fibrils)

4/2023	Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study.
4/2022	Mechanisms Involved in Epileptogenesis in Alzheimer's Disease and Their Therapeutic Implications.
1/2021	Biphasic cortical macro- and microstructural changes in autosomal dominant Alzheimer's disease.
1/2020	Obesity impacts brain metabolism and structure independently of amyloid and tau pathology in healthy elderly.
1/2019	Down syndrome, Alzheimer disease, and cerebral amyloid angiopathy: The complex triangle of brain amyloidosis.
1/2018	Challenges associated with biomarker-based classification systems for Alzheimer's disease.
11/2017	Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.
1/2016	Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation.
8/2015	Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease.
6/2015	Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

María Carmona-Iragui Research Topics

Disease

18	Alzheimer Disease (Alzheimer's Disease) 04/2023 - 01/2014
9	Down Syndrome (Down's Syndrome) 04/2023 - 01/2017
6	Dementia (Dementias) 04/2023 - 01/2014
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2014
4	Inflammation (Inflammations) 01/2021 - 01/2014
2	Cerebral Cortical Thinning 04/2023 - 09/2015
2	Neuroinflammatory Diseases 01/2021 - 08/2015
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2019 - 01/2016
2	Headache (Headaches) 01/2017 - 01/2014
2	Frontotemporal Dementia (Semantic Dementia) 01/2016 - 01/2014
2	Atrophy 09/2015 - 08/2014
2	Cognitive Dysfunction 06/2015 - 01/2014
1	Amyloidosis 12/2023
1	Chronic Renal Insufficiency 12/2023
1	Gliosis 04/2023
1	Epilepsy (Aura) 04/2022
1	Temporal Lobe Epilepsy 04/2022
1	Pneumonia (Pneumonitis) 08/2021
1	COVID-19 08/2021
1	Disease Progression 01/2021
1	Obesity 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019
1	Body-Weight Trajectory 12/2017
1	Intellectual Disability (Idiocy) 05/2017
1	Post-Dural Puncture Headache 01/2017
1	Arachnoiditis 07/2011
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2011

Drug/Important Bio-Agent (IBA)

22	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2014
12	Amyloid (Amyloid Fibrils)IBA 04/2023 - 01/2014
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2014
2	ProgranulinsIBA 01/2019 - 01/2016
2	Apolipoproteins E (ApoE)IBA 11/2017 - 09/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016 - 07/2011
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 08/2015 - 01/2014
1	Glial Fibrillary Acidic ProteinIBA 04/2023
1	Threonine (L-Threonine)FDA Link 01/2021
1	Inositol (Myoinositol)IBA 01/2021
1	N-acetylaspartate (N-acetyl aspartate)IBA 01/2021
1	Interferon Receptors (Interferon Receptor)IBA 10/2019
1	KynurenineIBA 10/2019
1	ApolipoproteinsIBA 11/2017
1	Analgesics (Analgesic Drugs)IBA 01/2017
1	AutoantibodiesIBA 01/2016
1	Apolipoprotein E4IBA 09/2015
1	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2011

Therapy/Procedure

1	Therapeutics 04/2023
1	Length of Stay 08/2021
1	Patient Positioning 01/2014